Cardiovascular disease remains the number one health problem in our society. Therefore, understanding the pathophysiology of cardiovascular disease processes at the molecular and cellular level, translating these insights into clinical practice through integrative physiologic investigation, and developing the appropriate approaches for delivering healthcare to our population through translational research remain high. This multidisciplinary research training program in cardiovascular disease has, therefore, the principal goal of training outstanding M.D. investigators, as well as highly motivated M.D./Ph.D. and Ph.D. scientists, for investigative careers as Medical School or University faculty. To achieve this goal, this multidisciplinary research training program is constructed with four fundamental components. Component one consists of two parallel research training tracts, one for basic and one for translational research. These parallel research training tracts have been focused principally in the areas of atherosclerosis, thrombosis, and vascular biology;cardiac muscle development, myocyte performance, and hypertrophy;signal transduction;and translational research. Component two consists of a highly developed didactic curriculum that can be individualized for each trainee, irrespective of whether they choose to pursue rigorous basic or translational investigation. Component three consists of common, didactic curricular elements, e.g. research conferences and seminars, a journal club, and a trainee association. These curricular elements provide a mechanism to address those educational deficiencies that all trainees have in common, including: research design and complex statistical methods, developing writing and speaking skills;and, most importantly, developing grant writing capabilities. To achieve these important educational objectives, component four is the commitment of the faculty mentors. Because of the multidisciplined nature of this research training program, the faculty mentors have forged a mutually shared mentorship philosophy, which represents a strong commitment to the individual success of each trainee, irrespective of their focus in basic or translational research. Because this represents an important time commitment, each faculty mentor has committed to, not just providing education to a trainee in their laboratory;but also to the common elements of this research training program. In aggregate, this multidisciplinary cardiovascular research training program is, therefore, designed to provide a rich, rigorous and varied educational experience leading to the acquisition of all the requisite skills by each trainee, irrespective of their prior research experience, to spend a productive and successful lifetime in research and, ultimately, assume their role as a member of a Medical School or University faculty

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007853-13
Application #
7798616
Study Section
Special Emphasis Panel (ZHL1-CSR-M (F1))
Program Officer
Commarato, Michael
Project Start
1996-09-30
Project End
2013-03-31
Budget Start
2010-04-01
Budget End
2011-03-31
Support Year
13
Fiscal Year
2010
Total Cost
$452,739
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Kataruka, Akash; Kong, Xiaowen; Haymart, Brian et al. (2017) SAMe-TT2R2 predicts quality of anticoagulation in patients with acute venous thromboembolism: The MAQI2 experience. Vasc Med 22:197-203
Bellumkonda, Lavanya; Tyrrell, Daniel; Hummel, Scott L et al. (2017) Pathophysiology of heart failure and frailty: a common inflammatory origin? Aging Cell 16:444-450
Sukul, Devraj; Seth, Milan; Dixon, Simon R et al. (2017) Contemporary Trends and Outcomes Associated With the Preprocedural Use of Oral P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). J Invasive Cardiol 29:340-351
Sukul, Devraj; Seth, Milan; Schreiber, Theodore et al. (2017) The comparative safety of abciximab versus eptifibatide in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). J Interv Cardiol 30:291-300
Frieler, Ryan A; Chung, Yutein; Ahlers, Carolyn G et al. (2017) Genetic neutrophil deficiency ameliorates cerebral ischemia-reperfusion injury. Exp Neurol 298:104-111
Sukul, Devraj; Bach, David S (2017) Readmissions after transcatheter aortic valve implantation. What are they doing right? How can we do better? Eur Heart J 38:2218-2220
Jacobs, Benjamin N; Cain-Nielsen, Anne H; Jakubus, Jill L et al. (2017) Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma. J Trauma Acute Care Surg 83:151-158
Colvin, Monica M; Smith, Candice A; Tullius, Stefan G et al. (2017) Aging and the immune response to organ transplantation. J Clin Invest 127:2523-2529
Bohannon, Kevin P; Bittner, Mary A; Lawrence, Daniel A et al. (2017) Slow fusion pore expansion creates a unique reaction chamber for co-packaged cargo. J Gen Physiol 149:921-934
Tyrrell, Daniel J; Bharadwaj, Manish S; Jorgensen, Matthew J et al. (2017) Blood-Based Bioenergetic Profiling Reflects Differences in Brain Bioenergetics and Metabolism. Oxid Med Cell Longev 2017:7317251

Showing the most recent 10 out of 107 publications